Thank you

For signing up for our enewsletter, Sight360

We look forward to sharing all of our eye-opening updates with you monthly. You can see the latest news and blog posts below, and you can follow us on Twitter, Facebook and YouTube for up-to-the-minute information.

SANDCAT

Jan 23 2023

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)

Read More

CapriCORN

Jan 23 2023

Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea

Read More

RECORDATI MT8

Jan 23 2023

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Read More

IMVT TED

Jan 23 2023

A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Read More
Dr. Alice McPherson

Remembering Dr. Alice McPherson

Jan 20 2023

With great sadness, the University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences mourns the passing of notable alumna, retina specialist, and vision research advocate Alice McPherson, MD on January 16th, 2023.

Read More
Sarah Gong, PhD

New Nanoparticles Deliver Therapy Brain-Wide, Edit Alzheimer’s Gene In Mice

Jan 20 2023

Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease.

Read More
Daniel Knoch, MD

UW Faculty Present at 2023 AUPO Annual Meeting

Jan 19 2023

University of Wisconsin Department of Ophthalmology and Visual Sciences faculty members and staff will present at the 2023 Association of University Professors of Ophthalmology (AUPO) Annual Meeting in San Diego, CA January 24 – 28,…

Read More